Does amoxicillin interact with standard renal‑transplant immunosuppressants (tacrolimus, cyclosporine, mycophenolate mofetil, azathioprine, sirolimus/everolimus, prednisone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin and Renal Transplant Medications: No Clinically Significant Interactions

Amoxicillin does not have clinically significant interactions with standard renal transplant immunosuppressants and can be safely prescribed to kidney transplant recipients.

Key Drug Interaction Principles in Renal Transplantation

The primary concern with antibiotics in transplant patients involves those that affect the cytochrome P450 3A4 system and P-glycoprotein pathways, which metabolize calcineurin inhibitors (tacrolimus, cyclosporine) and mTOR inhibitors (sirolimus, everolimus) 1.

Antibiotics That DO Cause Problems

The guidelines specifically identify problematic antibiotics 1:

  • Macrolide antibiotics (erythromycin, clarithromycin) - significantly increase CNI levels by inhibiting CYP3A4 1
  • Rifampin and rifabutin - dramatically decrease CNI and mTOR inhibitor levels by inducing CYP3A4 1
  • Imidazole antifungals - increase CNI concentrations 1

Why Amoxicillin is Safe

Amoxicillin is notably absent from all published lists of problematic antibiotics in transplant guidelines 1. This is because:

  • Amoxicillin is not metabolized via cytochrome P450 3A4 2, 3
  • It does not affect P-glycoprotein transport 1
  • It does not interfere with the metabolism of tacrolimus, cyclosporine, sirolimus, everolimus, mycophenolate, azathioprine, or prednisone 1

Specific Immunosuppressant Considerations

Calcineurin Inhibitors (Tacrolimus/Cyclosporine)

  • No interaction with amoxicillin - these drugs are metabolized by CYP3A4, which amoxicillin does not affect 1
  • No dose adjustment needed when prescribing amoxicillin 2, 3

Mycophenolate Mofetil

  • The FDA label for mycophenolate lists specific antibiotic interactions: amoxicillin is not among them 4
  • Problematic antibiotics for mycophenolate include rifampin (decreases levels), but not beta-lactams like amoxicillin 4

Azathioprine

  • The critical interaction is with allopurinol (can cause fatal bone marrow suppression), not with amoxicillin 1

mTOR Inhibitors (Sirolimus/Everolimus)

  • Only rifampin and rifabutin are listed as problematic antibiotics 1
  • Amoxicillin does not appear in interaction tables 1

Prednisone

  • No interaction with amoxicillin 1

Clinical Recommendations

Amoxicillin can be prescribed at standard doses without adjustment or additional monitoring in renal transplant recipients 1. The key principle from transplant guidelines is that clinicians should avoid antibiotics that affect CYP3A4 metabolism or contribute to nephrotoxicity 1.

Common Pitfalls to Avoid

  • Do not confuse amoxicillin with macrolides - while macrolides require careful monitoring and dose adjustments, amoxicillin does not 1
  • Aminoglycosides are the beta-lactam concern - these can potentiate CNI nephrotoxicity, but amoxicillin does not share this risk 1
  • Always notify the transplant center when prescribing new medications as a general principle, even though amoxicillin specifically does not require intervention 1

When to Exercise Caution

The only scenario requiring attention is if amoxicillin is combined with clavulanic acid in patients with pre-existing hepatic issues, though this relates to direct hepatotoxicity rather than drug interactions with immunosuppressants 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Interactions between tacrolimus and antimicrobial agents.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997

Research

[Drug interactions and immunosuppression in organ transplant recipients].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.